(Q34190402)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647578%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

title

Translational PK-PD modelling of molecular target modulation for the AMPA receptor positive allosteric modulator Org 26576 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647578%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647578%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author name string

Roberta Bursi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647578%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Gul Erdemli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647578%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Robert Campbell

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647578%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Matthew M Hutmacher

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647578%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Thomas Kerbusch

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647578%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Ross Jeggo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647578%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Kari R Nations

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647578%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Peter Dogterom

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647578%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Jacques Schipper

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647578%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Mohammed Shahid

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647578%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

publication date

7 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647578%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

number of pages

12

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647578%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

volume

218

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647578%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647578%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

page(s)

713-724

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647578%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00213-011-2365-6

3 February 2020

exact match

0 references

cites work

Pharmacology of ampakine modulators: from AMPA receptors to synapses and behavior

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

Ionotropic glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

Ionotropic glutamate receptors & CNS disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

Reversal of cognitive deficits by an ampakine (CX516) and sertindole in two animal models of schizophrenia--sub-chronic and early postnatal PCP treatment in attentional set-shifting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors reverses sub-chronic PCP-induced deficits in the novel object recognition task in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

A placebo-controlled pilot study of the ampakine CX516 added to clozapine in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

The ampakine, Org 26576, bolsters early spatial reference learning and retrieval in the Morris water maze: a subchronic, dose-ranging study in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

Activation of 5-HT1B and 5-HT1D receptors in the rat nucleus tractus solitarius: opposing action on neurones that receive an excitatory vagal C-fibre afferent input

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

Regionally selective and dose-dependent effects of the ampakines Org 26576 and Org 24448 on local cerebral glucose utilisation in the mouse as assessed by 14C-2-deoxyglucose autoradiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

Ionotropic and metabotropic glutamate receptor structure and pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

Antidepressant activity of memory-enhancing drugs in the reduction of submissive behavior model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

Effects of an AMPA receptor modulator on methamphetamine-induced hyperactivity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

Antidepressant-like actions of an AMPA receptor potentiator (LY392098).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

AMPA receptor modulators as cognitive enhancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

Glutamate-based therapeutic approaches: ampakines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

Ampakines and the threefold path to cognitive enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

Development of translational pharmacokinetic-pharmacodynamic models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

Use of viral promoters in mammalian cell-based bioassays: How reliable?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

Positive modulation of glutamatergic receptors potentiates the suppressive effects of antipsychotics on conditioned avoidance responding in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

AMPA receptor potentiators for the treatment of CNS disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

Neurotrophic actions of the novel AMPA receptor potentiator, LY404187, in rodent models of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

Facilitation of task performance and removal of the effects of sleep deprivation by an ampakine (CX717) in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

Pharmacokinetic/pharmacodynamic modeling in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

Chronic treatment with AMPA receptor potentiator Org 26576 increases neuronal cell proliferation and survival in adult rodent hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

Dopamine modulates temporal dynamics of feedforward inhibition in rat prefrontal cortex in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

Potentiation of responses to AMPA on central neurones by LY392098 and LY404187 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

Central nervous system pharmacokinetics of the Mdr1 P-glycoprotein substrate CP-615,003: intersite differences and implications for human receptor occupancy projections from cerebrospinal fluid exposures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

Assessment of actual significance levels for covariate effects in NONMEM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

Receptor occupancy and brain free fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

Acute effects of the ampakine farampator on memory and information processing in healthy elderly volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

Evaluation of the pro-cognitive effects of the AMPA receptor positive modulator, 5-(1-piperidinylcarbonyl)-2,1,3-benzoxadiazole (CX691), in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2365-6

The glutamate receptor ion channels

21 January 2018

1 reference

12 December 2020

Facilitative effects of the ampakine CX516 on short-term memory in rats: correlations with hippocampal neuronal activity.

1 reference

12 December 2020

Facilitative effects of the ampakine CX516 on short-term memory in rats: enhancement of delayed-nonmatch-to-sample performance.

1 reference

12 December 2020

Synergistic interactions between ampakines and antipsychotic drugs

1 reference

12 December 2020

Lost in Translation: Obstacles to Translational Medicine

1 reference

12 December 2020